WIPOSchützen Sie diese Marke vor Nachahmern!
Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.
Die Internationale Marke PROPHARMA wurde als Wortmarke am 03.01.2018 bei der Weltorganisation für geistiges Eigentum angemeldet.
| Markenform | Wortmarke |
| Aktenzeichen | 1406149 |
| Länder | 
|
| Basismarke |
Nr. 87565861,
11. August 2017
|
| Anmeldedatum | 03. Januar 2018 |
| Ablaufdatum | 03. Januar 2028 |
Markeninhaber
8717 W 110th Street, Suite 300
Overland Park KS 66210
US
Overland Park KS 66210
US
Markenvertreter
10801 Mastin Blvd., Suite 1000
Overland Park KS 66210
US
Waren und Dienstleistungen
35
Business information and business consulting services,
namely, providing business advisory services to identify,
screen, and select contract manufacturing organizations to
contract and build medical and pharmaceutical products and
devices; providing business advisory services to health care
providers, namely, designing the administrative, financial
and clinical workflows associated with value-based
healthcare delivery models; providing business assistance to
healthcare providers in the field of enabling communication
and collaboration for the purpose of developing,
implementing and evaluating patient care plans; business
services, namely, tracking and monitoring regulatory
requirements in the pharmaceutical, biotechnology, and
medical fields for business purposes; maintaining files and
records concerning the medical condition of individuals;
maintaining personal medical history records and files;
business consulting services in the medical, pharmaceutical,
and biotechnology fields
42
Providing quality assurance services in the medical,
pharmaceutical, and biotechnology fields; quality management
services, namely, quality evaluation and analysis, quality
assurance, and quality control, in the medical,
pharmaceutical, and biotechnology fields; testing, analysis,
and evaluation of medical, pharmaceutical, and biotechnology
services to assure compliance with industry standards;
tracking and monitoring regulatory requirements in the
pharmaceutical, biotechnology, and medical fields for
quality control purposes
44
Providing medical and pharmaceutical information services,
namely, drug interaction information via call centers,
adverse event reporting services for drugs and medical
devices and product compliant reporting services for drugs
and medical device; medical information; providing medical
information, consultancy and advisory services; health care
consulting, namely, aggregating clinical, claims,
socioeconomic and behavioral health data for the purpose of
improving healthcare providers' evaluation of health
conditions and health risks with individual patients,
cohorts of patients, and populations; health care
consulting, namely, assessing patient and population health
profiles using evidence-based medical guidelines for the
purpose of improving healthcare provider treatment decisions
at the point of care; providing information over a global
computer network in the field of health care; providing
medical information, consultancy, and advisory services,
namely, providing healthcare providers, insurance companies,
and healthcare product manufacturers with information and
statistics regarding patient medication intake, schedule
compliance, and health status
45
Regulatory compliance consulting in the pharmaceutical,
biotechnology, and medical fields; regulatory compliance
consulting in the fields of drug and device development and
manufacturing; tracking and monitoring regulatory
requirements in the pharmaceutical, biotechnology, and
medical fields for legal or regulatory compliance purposes;
tracking and monitoring regulatory requirements in the field
of drug and device development and manufacturing for
regulatory compliance purposes
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen
Markenhistorie
| Datum | Belegnummer | Bereich | Eintrag |
|---|---|---|---|
| 27. Januar 2021 | 2021/6 Gaz | RAW: Holder Rights Restriction | |
| 04. Juni 2020 | 2020/24 Gaz | JP | RAW: Rule 18ter(2)(i) GP following a provisional refusal |
| 22. April 2020 | 2020/19 Gaz | AU | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 27. Dezember 2019 | 2020/4 Gaz | RAW: Limitation | |
| 14. März 2019 | 2019/11 Gaz | JP | Ablehnung |
| 24. Januar 2019 | 2019/8 Gaz | CN | Ablehnung |
| 12. Dezember 2018 | 2018/50 Gaz | GB | Ablehnung |
| 12. Dezember 2018 | 2019/1 Gaz | Löschung | |
| 27. November 2018 | 2019/13 Gaz | AU | Ablehnung |
| 25. Oktober 2018 | 2018/44 Gaz | EM | Ablehnung |
| 20. Juni 2018 | 2018/26 Gaz | EM | Ablehnung |
| 03. Januar 2018 | 2018/21 Gaz | US | Eintragung |
ID: 141406149